Soru

Zorluk: Çok zorFormulating a Differential Diagnosis

A 68-year-old man presents to the emergency department with a 3-day history of progressive fatigue, decreased urine output, and a severe, deep aching pain in his right foot. Eighteen days ago, he was hospitalized for a non-ST-segment elevation myocardial infarction, which was treated with coronary angiography and drug-eluting stent placement via a right femoral artery approach. He was discharged on aspirin, clopidogrel, atorvastatin, ramipril, and bisoprolol.

On physical examination, his temperature is 37.9°C (100.2°F), blood pressure is 155/90 mm Hg, and heart rate is 82/min. The right first and second digits are cyanotic, cool, and exquisitely tender to palpation, though the right dorsalis pedis and posterior tibial pulses are full and symmetric to the left. A lace-like, non-blanching purplish discoloration is present over his bilateral lower extremities.

Laboratory studies show:
BUN: 54 mg/dL
Creatinine: 3.2 mg/dL (baseline 1.1 mg/dL)
WBC count: 11,200/mm³ with 12% eosinophils
Platelets: 210,000/mm³
Serum complement C3: 72 mg/dL (normal: 90-180 mg/dL)

Urinalysis reveals a specific gravity of 1.015, 1+ protein, 5-10 WBCs/hpf, and 1-2 RBCs/hpf. A Wright stain of the urine is positive for eosinophils. No granular or muddy brown casts are seen.

Based on the clinical presentation and laboratory findings, which of the following is the most likely diagnosis?

  1. A
    Acute interstitial nephritis
  2. Cholesterol embolization syndromeCevap
  3. C
    Contrast-induced acute tubular necrosis
  4. D
    Heparin-induced thrombocytopenia with thrombosis
  5. E
    Polyarteritis nodosa

Cevap

The most likely diagnosis is Cholesterol embolization syndrome.
The correct diagnosis is Cholesterol embolization syndrome (CES). CES occurs when an atherosclerotic plaque is mechanically disrupted, typically during endovascular procedures like coronary angiography via a femoral approach. Cholesterol crystals shower the systemic circulation and lodge in small arterioles. In the kidneys, this causes a subacute kidney injury that classically manifests 1 to 4 weeks post-procedure. In the skin, microemboli cause livedo reticularis and 'blue toe syndrome' (tissue ischemia with preserved large-vessel pulses, such as the dorsalis pedis). The exposed cholesterol clefts trigger a prominent systemic inflammatory response, leading to characteristic laboratory findings: eosinophilia, eosinophiluria, and transient hypocomplementemia.

Adım Adım Çözüm

1
Identify the primary clinical syndrome from the patient's presentation.
The patient has subacute acute kidney injury, cutaneous signs of microembolization (livedo reticularis, cyanotic digits with intact pulses), and systemic inflammation (fever, eosinophilia).
Grouping findings into a cohesive syndrome prevents fixation on isolated symptoms and guides the differential diagnosis.
2
Evaluate the timeline relative to recent medical interventions.
The symptoms and lab abnormalities are occurring approximately 3 weeks post-cardiac catheterization.
The timeline definitively rules out contrast-induced nephropathy, which typically peaks at 48-72 hours and resolves within a week.
3
Analyze the specific laboratory abnormalities.
The presence of eosinophilia, eosinophiluria, and hypocomplementemia indicates a systemic inflammatory/immunologic response.
While acute interstitial nephritis (AIN) shares the eosinophil findings, it cannot explain the hypocomplementemia or the distal microembolic skin findings.
4
Synthesize the data to formulate the final differential.
The combination of recent endovascular manipulation, distal microvascular occlusion with intact large-vessel pulses, AKI, and an eosinophilic/hypocomplementemic inflammatory response points exclusively to cholesterol crystal embolization.
Disruption of atherosclerotic plaques during catheterization releases cholesterol crystals that lodge in small arterioles, triggering a foreign-body inflammatory reaction.

Anahtar Kavram

Differentiating etiologies of post-catheterization acute kidney injury by integrating physical findings (microemboli) and specific inflammatory markers (eosinophilia, hypocomplementemia).
Tahmini Süre:2m 0s
Bu soruyu puanla